Goodwin Chosen for Proof-of-Concept Development on Anthrax Vaccine
Emergent BioSolutions has selected Goodwin Biotechnology to perform process development for its anthrax vaccine.
Archives for June 4, 2013
QPS Selects Hepregen to Boost Preclinical Metabolism Services
Hepregen has agreed to provide US CRO QPS Holdings with long-term liver cell models to aid its offerings in drug metabolism and pharmacokinetic (DMPK) services.